Market Overview:
The global prefilled syringes drug molecules market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for vaccines, insulin, adrenaline, and opioids due to their high efficacy and safety profiles. In addition, the increasing use of online pharmacies is also contributing to the growth of this market. Regionally, North America dominates the global prefilled syringes drug molecules market followed by Europe and Asia Pacific. The dominance of these regions can be attributed to factors such as rising prevalence of chronic diseases, growing geriatric population, and increasing demand for innovative drugs & therapies.
Product Definition:
Prefilled syringes are medical devices that contain a specific dose of medication. The syringe is filled with the drug by the manufacturer, and then sealed until it is ready for use. This eliminates the need to measure out the drug prior to injection, which can be inaccurate and dangerous.
Vaccines:
Vaccines are biological agents that are used to stimulate the body's immune system to respond, usually against a foreign substance such as bacteria, viruses or toxins. The most common way of vaccinating is by using vaccines for diseases like measles, polio and hepatitis. Vaccination helps the body's immune system learn how to protect itself from similar future threats.
Insulin:
Insulin is a hormone, which facilitates the entry of glucose into the blood cells. The body’s inability to produce an appropriate amount of insulin leads to increased sugar in the bloodstream leading to frequent urination, fatigue, and headache among other symptoms. Insulin acting as a growth factor for cancer cells results in increasing cancer prevalence worldwide.
Application Insights:
The global market is segmented by application into retail pharmacies, hospital pharmacies and online pharmacies. The retail pharmacy segment dominated the market in 2017 owing to an increase in demand for cost-effective medicines among consumers. According to a study published by the National Center for Biotechnology Information (NCBI) in 2012, it was estimated that around 70% of all prescriptions are filled through retail outlets across the globe.
Hospital pharmacists fill about 80% of all drug prescriptions written at hospitals and health centers while about 90% of all antibiotics are prescribed from primary care physicians or family doctors at clinics or hospitals according to data published by CDC (Center For Disease Control And Prevention). Thus, increasing prevalence of chronic diseases such as cancer, diabetes and cardiovascular disorders coupled with rising healthcare expenditure will boost industry growth over the forecast period.
Regional Analysis:
North America dominated the global prefilled syringes drug molecules market in 2017. The growth can be attributed to various factors such as high healthcare expenditure, rising prevalence of chronic diseases, and increasing adoption of advanced technologies for medication. Moreover, growing demand for generic drugs due to the presence of numerous manufacturers is expected to further drive the regional market over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to several initiatives undertaken by governments in developing economies aimed at improving healthcare facilities and infrastructure coupled with an increase in government spending on pharmaceuticals sector. In addition, favorable regulatory policies are expected boost revenue generation opportunities for all participants across this region over a projected timeframe (from 2018 through 2030).
Furthermore, economic development coupled with rise in disposable income has led many people opt for private health insurance plans which covers hospital visits and prescriptions; thereby boosting revenue generation across this region (2018 through 2030).
Growth Factors:
- Increasing prevalence of chronic diseases: The global prevalence of chronic diseases is increasing at an alarming rate. This is primarily because of the changing lifestyles and dietary habits of people across the world. Prefilled syringes are increasingly being used to administer drugs for the treatment of various chronic diseases, such as diabetes, cancer, and rheumatoid arthritis.
- Technological advancements: The prefilled syringe market is witnessing rapid technological advancements, with new products being launched regularly in order to cater to the needs of different customer segments. These advancements are helping to improve the efficiency and accuracy of drug delivery through prefilled syringes.
- Rising demand from emerging markets: A large number of emerging markets are experiencing high growth rates due to their burgeoning population and rapidly expanding economies. This is resulting in a rising demand for prefilled syringes from these regions, as healthcare providers seek to improve access to quality medical care for their citizens.
Scope Of The Report
Report Attributes
Report Details
Report Title
Prefilled Syringes Drug Molecules Market Research Report
By Type
Vaccines, Insulin, Adrenaline, Opioids, Others
By Application
Retail Pharmacies, Hospital Pharmacies, Online Pharmacies
By Companies
Merck, AstraZeneca, Johnson & Johnson, SANOFI, Mylan, Amgen, Novartis, Teva Pharmaceutical Industries, Pfizer, GSK, Merck
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
171
Number of Tables & Figures
120
Customization Available
Yes, the report can be customized as per your need.
Global Prefilled Syringes Drug Molecules Market Report Segments:
The global Prefilled Syringes Drug Molecules market is segmented on the basis of:
Types
Vaccines, Insulin, Adrenaline, Opioids, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Retail Pharmacies, Hospital Pharmacies, Online Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Merck
- AstraZeneca
- Johnson & Johnson
- SANOFI
- Mylan
- Amgen
- Novartis
- Teva Pharmaceutical Industries
- Pfizer
- GSK
- Merck
Highlights of The Prefilled Syringes Drug Molecules Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Vaccines
- Insulin
- Adrenaline
- Opioids
- Others
- By Application:
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Prefilled Syringes Drug Molecules Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Prefilled syringes are drug molecules that have been filled with a specific medication. These pre-filled syringes can be used to administer medications directly to the patient's bloodstream, bypassing the need for an injection needle.
Some of the major companies in the prefilled syringes drug molecules market are Merck, AstraZeneca, Johnson & Johnson, SANOFI, Mylan, Amgen, Novartis, Teva Pharmaceutical Industries, Pfizer, GSK, Merck.
The prefilled syringes drug molecules market is expected to grow at a compound annual growth rate of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Prefilled Syringes Drug Molecules Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Prefilled Syringes Drug Molecules Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Prefilled Syringes Drug Molecules Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Prefilled Syringes Drug Molecules Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Prefilled Syringes Drug Molecules Market Size & Forecast, 2018-2028
4.5.1 Prefilled Syringes Drug Molecules Market Size and Y-o-Y Growth
4.5.2 Prefilled Syringes Drug Molecules Market Absolute $ Opportunity
Chapter 5 Global Prefilled Syringes Drug Molecules Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Prefilled Syringes Drug Molecules Market Size Forecast by Type
5.2.1 Vaccines
5.2.2 Insulin
5.2.3 Adrenaline
5.2.4 Opioids
5.2.5 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Prefilled Syringes Drug Molecules Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Prefilled Syringes Drug Molecules Market Size Forecast by Applications
6.2.1 Retail Pharmacies
6.2.2 Hospital Pharmacies
6.2.3 Online Pharmacies
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Prefilled Syringes Drug Molecules Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Prefilled Syringes Drug Molecules Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Prefilled Syringes Drug Molecules Analysis and Forecast
9.1 Introduction
9.2 North America Prefilled Syringes Drug Molecules Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Prefilled Syringes Drug Molecules Market Size Forecast by Type
9.6.1 Vaccines
9.6.2 Insulin
9.6.3 Adrenaline
9.6.4 Opioids
9.6.5 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Prefilled Syringes Drug Molecules Market Size Forecast by Applications
9.10.1 Retail Pharmacies
9.10.2 Hospital Pharmacies
9.10.3 Online Pharmacies
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Prefilled Syringes Drug Molecules Analysis and Forecast
10.1 Introduction
10.2 Europe Prefilled Syringes Drug Molecules Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Prefilled Syringes Drug Molecules Market Size Forecast by Type
10.6.1 Vaccines
10.6.2 Insulin
10.6.3 Adrenaline
10.6.4 Opioids
10.6.5 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Prefilled Syringes Drug Molecules Market Size Forecast by Applications
10.10.1 Retail Pharmacies
10.10.2 Hospital Pharmacies
10.10.3 Online Pharmacies
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Prefilled Syringes Drug Molecules Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Prefilled Syringes Drug Molecules Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Prefilled Syringes Drug Molecules Market Size Forecast by Type
11.6.1 Vaccines
11.6.2 Insulin
11.6.3 Adrenaline
11.6.4 Opioids
11.6.5 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Prefilled Syringes Drug Molecules Market Size Forecast by Applications
11.10.1 Retail Pharmacies
11.10.2 Hospital Pharmacies
11.10.3 Online Pharmacies
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Prefilled Syringes Drug Molecules Analysis and Forecast
12.1 Introduction
12.2 Latin America Prefilled Syringes Drug Molecules Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Prefilled Syringes Drug Molecules Market Size Forecast by Type
12.6.1 Vaccines
12.6.2 Insulin
12.6.3 Adrenaline
12.6.4 Opioids
12.6.5 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Prefilled Syringes Drug Molecules Market Size Forecast by Applications
12.10.1 Retail Pharmacies
12.10.2 Hospital Pharmacies
12.10.3 Online Pharmacies
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Prefilled Syringes Drug Molecules Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Prefilled Syringes Drug Molecules Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Prefilled Syringes Drug Molecules Market Size Forecast by Type
13.6.1 Vaccines
13.6.2 Insulin
13.6.3 Adrenaline
13.6.4 Opioids
13.6.5 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Prefilled Syringes Drug Molecules Market Size Forecast by Applications
13.10.1 Retail Pharmacies
13.10.2 Hospital Pharmacies
13.10.3 Online Pharmacies
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Prefilled Syringes Drug Molecules Market: Competitive Dashboard
14.2 Global Prefilled Syringes Drug Molecules Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Merck
14.3.2 AstraZeneca
14.3.3 Johnson & Johnson
14.3.4 SANOFI
14.3.5 Mylan
14.3.6 Amgen
14.3.7 Novartis
14.3.8 Teva Pharmaceutical Industries
14.3.9 Pfizer
14.3.10 GSK
14.3.11 Merck
